Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mind Medicine Mindmed Inc (MNMD)

Mind Medicine Mindmed Inc (MNMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 675,661
  • Shares Outstanding, K 76,088
  • Annual Sales, $ 0 K
  • Annual Income, $ -108,680 K
  • EBIT $ -130 M
  • EBITDA $ -129 M
  • 60-Month Beta 2.49
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.01

Options Overview Details

View History
  • Implied Volatility 66.61% ( +3.32%)
  • Historical Volatility 67.14%
  • IV Percentile 2%
  • IV Rank 8.69%
  • IV High 151.81% on 02/05/25
  • IV Low 58.49% on 10/01/24
  • Put/Call Vol Ratio 0.29
  • Today's Volume 3,775
  • Volume Avg (30-Day) 1,633
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 48,060
  • Open Int (30-Day) 48,644

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate -0.50
  • Number of Estimates 4
  • High Estimate -0.40
  • Low Estimate -0.58
  • Prior Year -0.27
  • Growth Rate Est. (year over year) -85.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.96 +11.56%
on 08/01/25
11.02 -19.42%
on 08/25/25
-0.26 (-2.84%)
since 07/29/25
3-Month
6.34 +40.06%
on 06/23/25
11.02 -19.42%
on 08/25/25
+1.62 (+22.31%)
since 05/29/25
52-Week
4.70 +88.94%
on 04/09/25
11.02 -19.42%
on 08/25/25
+3.02 (+51.41%)
since 08/28/24

Most Recent Stories

More News
MindMed to Participate in September Investor Conferences

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

MNMD : 8.88 (-9.20%)
MindMed Announces New Employee Inducement Grants

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

MNMD : 8.88 (-9.20%)
Get a FREE 1-Year Subscription to Barchart Premier! Open and Fund a Plus500 Futures Account and Make a Trade

Barchart Premier provides futures traders with historical data, advanced charting, watchlists, & screeners to help make smarter decisions. Join 30M+ people worldwide who use Plus500!

Could This Psychedelic Drug Stock Be a Top Buy for 2026?

With Phase 3 results for its lead psychedelic therapy expected next year, is now the right time to take a bold bet on MNMD stock?

$SPX : 6,460.26 (-0.64%)
MNMD : 8.88 (-9.20%)
MindMed Reports Q2 2025 Financial Results and Business Updates

--Strong enrollment continues in all three Phase 3 trials of MM120 Orally Disintegrating Tablet (ODT) in Generalized Anxiety Disorder (GAD) and Major Depressive Disorder...

MNMD : 8.88 (-9.20%)
MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

MNMD : 8.88 (-9.20%)
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

CMPS : 4.42 (-8.11%)
CYBN.NE : 10.3200 (-1.71%)
ATAI : 4.58 (-1.51%)
MMED.NE : 14.9000 (+9.48%)
SAGE : 8.68 (-0.23%)
MNMD : 8.88 (-9.20%)
CYBN : 7.48 (-2.09%)
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END

CMPS : 4.42 (-8.11%)
CYBN.NE : 10.3200 (-1.71%)
ATAI : 4.58 (-1.51%)
MMED.NE : 14.9000 (+9.48%)
SAGE : 8.68 (-0.23%)
MNMD : 8.88 (-9.20%)
CYBN : 7.48 (-2.09%)
Why Mind Medicine Gave Investors a Powerful Buzz in May

MNMD : 8.88 (-9.20%)
2 ‘Strong Buy’ Psychedelic Stocks to Scoop Up ASAP

Two psychedelic-focused stocks stand to benefit after the FDA designated psychedelics as a top review priority.

ATAI : 4.58 (-1.51%)
MNMD : 8.88 (-9.20%)

Business Summary

Mind Medicine Inc. is a clinical-stage psychedelic medicine biotech company. It discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Mind Medicine Inc. is based in New York, United States.

See More

Key Turning Points

3rd Resistance Point 10.74
2nd Resistance Point 10.29
1st Resistance Point 9.59
Last Price 8.88
1st Support Level 8.44
2nd Support Level 7.99
3rd Support Level 7.29

See More

52-Week High 11.02
Last Price 8.88
Fibonacci 61.8% 8.61
Fibonacci 50% 7.86
Fibonacci 38.2% 7.11
52-Week Low 4.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar